Preparation method and application of carboxyl-containing semi-sandwich type iridium complex
By selectively removing protons from the phenolic hydroxyl group, the semisandwich iridium complex containing carboxylate was solved, and the toxicity and resistance of existing platinum drugs were prepared through ligand design to prepare excellent anti-tumor effects. The new complex of the product has achieved efficient improvement in anti-cancer activity.
Patent Information
- Application Number
- CN202411041372.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-31
- Publication Date
- 2024-11-19
- Estimated Expiration
- 2044-07-31
AI Technical Summary
Existing platinum-based anti-cancer drugs have high toxicity, adverse side effects and drug resistance problems. When synthesizing semi-sandwich iridium complexes, the deprotonation process of carboxylic ligands is prone to compete for coordination with metals, resulting in a messy or inability to react. Obtain the target complex.
By selectively removing protons on the phenolic hydroxyl group and avoiding reaction with protons on the carboxyl group, the semi-sandwich N^O chelating complex containing carboxyl groups was successfully synthesized, and by introducing ligand designs with different substituents, an excellent one was prepared A novel semisandwich iridium complex with anti-tumor effects.
The efficient preparation of carboxyl-containing semisandwich iridium complex was achieved, which significantly improved its anti-cancer activity, was better than the carboxyl-free complex, showed excellent anti-tumor effect, and had the potential to be a new anti-cancer drug.
Smart Images

Figure CN118978551A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to a metal complex, in particular to a preparation method and application of a carboxyl-containing half-sandwich type iridium complex, belonging to the field of chemical pharmacy. Background Art
[0002] The rapid increase in cancer cases worldwide has created an indispensable need for the development and screening of potential anticancer drugs. For decades, cisplatin and its derivatives have been successfully used in the treatment of malignant tumors and have achieved great success. However, the currently widely used platinum anticancer drugs are accompanied by many disadvantages, including high toxicity, adverse side effects and drug resistance. The advantages and limitations of cisplatin-based chemotherapy drugs have prompted further research on alternative metal anticancer complexes. Some new organometallic complexes are considered to be the most promising anticancer agents due to their diverse structures, potential redox characteristics and a wide range of ligand substitution rates. For example, iridium (III), iron (II), ruthenium (II) and rhodium (II) have been used in the field of antitumor research and achieved ideal results. Among them, semi-sandwich metal iridium complexes have attracted widespread attention due to their easily adjustable structure, excellent anticancer activity and specific mechanism of action (MoAs). Currently, a large number of such complexes synthesized are generally divided into cationic complexes and neutral complexes. The cationic (metal center is in the form of cation) half sandwich iridium complexes of N^N two-dentate chelating ligands and the neutral (metal center is electrically neutral) half sandwich iridium complexes of C^N two-dentate chelating ligands synthesized by Peter J.Saler (see formula a and b below, Acc.Chem.Res.2014,47,1174-1185). In the cationic half sandwich iridium complex (see formula a below), the ligand adopts a two-dentate neutral chelation mode, the metal center is in the form of cation, and is balanced by external anions. In contrast, in the neutral half sandwich iridium complex (see formula b below), the two-dentate chelating ligand is negatively charged (usually negative monovalent), the entire complex remains neutral, and there is no counter ion.
[0003] Carboxyl groups are widely present in many drug molecules and can interact specifically with target molecules to exert therapeutic effects. Carboxyl groups are hydrophilic groups that can enhance the solubility of drugs for drug administration. At the same time, carboxyl groups can improve the stability and controlled release of drugs, as well as improve drug absorption and delivery. By rationally designing and modifying carboxylic acid groups, the targeting and selectivity of drugs can also be enhanced, and side effects can be reduced. Therefore, by introducing carboxyl groups, the anticancer activity of metal complexes can be better improved, and apoptosis of cancer cells can be promoted. It should be pointed out that since the carboxyl groups on carboxylic acid ligands can be bonded and coordinated with metals in the same plane, and protons can be partially or completely removed during the coordination process, the introduction of carboxyl groups in ligands may compete with the chelating sites in the ligands for coordination with the metals, resulting in a messy reaction or even failure to obtain the target complex.
[0004] Summary of the invention
[0005] In the system of the present invention, the phenolic hydroxyl groups on the ligands are selectively deprotonated by alkali or alkaline solvents without reacting with the protons on the carboxyl groups, thereby successfully achieving the synthesis of carboxyl-containing half-sandwich type N^O chelate complexes, and the anticancer activity of the carboxyl-containing complexes is superior to that of the complexes without carboxyl groups.
[0006] A series of carboxyl-containing ligands with different substituents are introduced to obtain a series of novel half-sandwich iridium complexes with good anti-tumor effects. Such novel half-sandwich iridium complexes show excellent anti-tumor effects.
[0007] The molecular structure of the carboxyl-containing half-sandwich iridium complex is:
[0008]
[0009] In the formula, R1, R2, and R3 can be hydrogen, C1-C 15 Alkyl, halogen or halogenated C1~C 15 An alkyl group; R4 is R5 is one of Cl, CH3O, CH3COO, and triphenylphosphine.
[0010] The carboxyl-containing half-sandwich type iridium complex described in the present invention, in the formula (I), R1 is hydrogen, R2 is hydrogen, R3 is hydrogen, and R4 is R5 is Cl, and the specific structural formula is shown in Formula 1; in Formula (I), R1 is fluorine, R2 is hydrogen, R3 is hydrogen, and R4 is R5 is Cl, and the specific structural formula is shown in Formula 2; in the formula (I), R1 is hydrogen, R2 is hydrogen, R3 is tert-butyl, and R4 is R5 is Cl, and the specific structural formula is shown in Formula 3; in Formula (I), R1 is fluorine, R2 is hydrogen, R3 is tert-butyl, and R4 is R5 is Cl, and the specific structural formula is shown in Formula 4; in Formula (I), R1 is hydrogen, R2 is tert-butyl, R3 is tert-butyl, and R4 is R5 is Cl, and the specific structural formula is shown in Formula 5; in the formula (I), R1 is fluorine, R2 is tert-butyl, R3 is tert-butyl, and R4 is R5 is Cl, and the specific structural formula is shown in Formula 6; in Formula (I), R1 is hydrogen, R2 is hydrogen, R3 is hydrogen, and R4 is R5 is Cl, and the specific structural formula is shown in Formula 7; in Formula (I), R1 is fluorine, R2 is hydrogen, R3 is hydrogen, and R4 is R5 is Cl, and the specific structural formula is shown in Formula 8; in the formula (I), R1 is hydrogen, R2 is hydrogen, R3 is hydrogen, and R4 is R5 is Cl, and the specific structural formula is shown in Formula 9; in Formula (I), R1 is fluorine, R2 is hydrogen, R3 is hydrogen, and R4 is R5 is Cl, and the specific structural formula is shown in Formula 10; in Formula (I), R1 is hydrogen, R2 is hydrogen, R3 is hydrogen, and R4 is R5 is Cl, and the specific structural formula is shown in Formula 11; in Formula (I), R1 is fluorine, R2 is hydrogen, R3 is hydrogen, and R4 is R5 is Cl, and the specific structural formula is shown in Formula 12;
[0011]
[0012] The preparation method of the carboxyl-containing half-sandwich type iridium complex of the present invention comprises the following steps: under nitrogen protection, a dimer represented by formula (III), a carboxyl-containing ligand represented by formula (II), a base or an alkaline solvent B are reacted at room temperature for 8 hours with methanol as a solvent to obtain the carboxyl-containing half-sandwich type iridium complex represented by formula (I); the complex is an 18-electron complex, and when sodium methoxide or sodium acetate is added as B, the purpose is to remove a proton H on the phenolic hydroxyl group of the ligand so that the ligand becomes an anionic ligand and coordinates with the metal center as a N^O chelating ligand; this process requires the base or alkaline solvent B to selectively remove the proton on the phenolic hydroxyl group in the ligand without reacting with the carboxyl group, and the specific synthesis route is:
[0013]
[0014] When the complex is 1, it is prepared by the following method:
[0015] Under nitrogen protection, 30.05 mg of iridium dimer (Formula (III)) was added into a 100 mL Schlenk bottle. 18.66 mg of ligand (formula (II) R1=R2=R3=hydrogen), 20 mg of sodium acetate and 10 mL of anhydrous methanol were reacted at room temperature for 12 h. After the reaction was completed, the solvent was dried by rotary evaporation, and the remaining solid was dissolved with dichloromethane. The sodium acetate was removed by sand core filtration. The filtrate was spun down to a minimum amount by rotary evaporation, and an excess of a poor solvent n-hexane was added to produce a precipitate. The precipitate was filtered by sand core and washed with n-hexane, and dried in vacuo to obtain a red solid 1.
[0016] When the complex is 2, it is prepared by the following method:
[0017] Under nitrogen protection, 30.02 mg of iridium dimer (Formula (III)) was added into a 100 mL Schlenk bottle. 19.95 mg of ligand (formula (II) R1 = fluorine, R2 = R3 = hydrogen), 20 mg of sodium acetate and 10 mL of anhydrous methanol were reacted at room temperature for 12 h. After the reaction was completed, the solvent was dried by rotary evaporation, and the remaining solid was dissolved with dichloromethane. The sodium acetate was removed by sand core filtration. The filtrate was spun down to a minimum amount by rotary evaporation, and an excess of a poor solvent n-hexane was added to produce a precipitate. The precipitate was filtered through a sand core and washed with n-hexane, and dried in vacuo to obtain a red solid 2.
[0018] When the complex is 3, it is prepared by the following method:
[0019] Under nitrogen protection, 30.02 mg of iridium dimer (Formula (III)) was added into a 100 mL Schlenk bottle. 22.89 mg of ligand (formula (II) R1 = R2 = hydrogen, R3 = tert-butyl), 20 mg of sodium acetate and 10 mL of anhydrous methanol were reacted at room temperature for 12 h. After the reaction was completed, the solvent was dried by rotary evaporation, and the remaining solid was dissolved with dichloromethane. The sodium acetate was removed by sand core filtration. The filtrate was spun down to a minimum amount by rotary evaporation, and an excess of a poor solvent n-hexane was added to produce a precipitate. The precipitate was filtered through a sand core and washed with n-hexane, and dried in vacuo to obtain a red solid 3.
[0020] When the complex is 4, it is prepared by the following method:
[0021] Under nitrogen protection, 30.02 mg of iridium dimer (Formula (III)) was added into a 100 mL Schlenk bottle. 23.96 mg of ligand (formula (II) R1 = fluorine, R2 = hydrogen, R3 = tert-butyl), 20 mg of sodium acetate and 10 mL of anhydrous methanol were reacted at room temperature for 12 h. After the reaction was completed, the solvent was dried by rotary evaporation, and the remaining solid was dissolved with dichloromethane. The sodium acetate was removed by sand core filtration. The filtrate was spun down to a minimum amount by rotary evaporation, and an excess of a poor solvent n-hexane was added to produce a precipitate. The precipitate was filtered through a sand core and washed with n-hexane, and dried in vacuo to obtain a red solid 4.
[0022] When the complex is 5, it is prepared by the following method:
[0023] Under nitrogen protection, 30.05 mg of iridium dimer (Formula (III)) was added into a 100 mL Schlenk bottle. 26.78 mg of ligand (formula (II) R1 = hydrogen, R2 = R3 = tert-butyl), 20 mg of sodium acetate and 10 mL of anhydrous methanol were reacted at room temperature for 12 h. After the reaction was completed, the solvent was dried by rotary evaporation, and the remaining solid was dissolved with dichloromethane. The sodium acetate was removed by sand core filtration. The filtrate was spun down to a minimum amount by rotary evaporation, and an excess of a poor solvent n-hexane was added to produce a precipitate. The precipitate was filtered through a sand core and washed with n-hexane, and dried in vacuo to obtain a red solid 5.
[0024] When the complex is 6, it is prepared by the following method:
[0025] Under nitrogen protection, 29.99 mg of iridium dimer (Formula (III)) was added into a 100 mL Schlenk bottle. 28.12 mg of ligand (formula (II) R1 = fluorine, R2 = R3 = tert-butyl), 20 mg of sodium acetate and 10 mL of anhydrous methanol were reacted at room temperature for 12 h. After the reaction was completed, the solvent was dried by rotary evaporation, and the remaining solid was dissolved with dichloromethane. The sodium acetate was removed by sand core filtration. The filtrate was spun down to a minimum amount by rotary evaporation, and an excess of a poor solvent n-hexane was added to produce a precipitate. The precipitate was filtered by sand core and washed with n-hexane, and dried in vacuo to obtain a red solid 6.
[0026] When the complex is 7, it is prepared by the following method:
[0027] Under nitrogen protection, 54.98 mg of iridium dimer (Formula (III)) was added into a 100 mL Schlenk bottle. 24.88 mg of ligand (formula (II) R1=R2=R3=hydrogen), 20 mg of sodium acetate and 10 mL of anhydrous methanol were reacted at room temperature for 12 h. After the reaction was completed, the solvent was dried by rotary evaporation, and the remaining solid was dissolved with dichloromethane. The sodium acetate was removed by sand core filtration. The filtrate was spun down to a minimum amount by rotary evaporation, and an excess of a poor solvent n-hexane was added to produce a precipitate. The precipitate was filtered by sand core and washed with n-hexane, and dried in vacuo to obtain a red solid 7.
[0028] When the complex is 8, it is prepared by the following method:
[0029] Under nitrogen protection, 50.06 mg of iridium dimer (Formula (III)) was added into a 100 mL Schlenk bottle. 24.55 mg of ligand (formula (II) R1 = fluorine, R2 = R3 = hydrogen), 20 mg of sodium acetate and 10 mL of anhydrous methanol were reacted at room temperature for 12 h. After the reaction was completed, the solvent was dried by rotary evaporation, and the remaining solid was dissolved with dichloromethane. The sodium acetate was removed by sand core filtration. The filtrate was spun down to a minimum amount by rotary evaporation, and an excess of a poor solvent n-hexane was added to produce a precipitate. The precipitate was filtered by sand core and washed with n-hexane, and dried in vacuo to obtain a red solid 8.
[0030] When the complex is 9, it is prepared by the following method:
[0031] Under nitrogen protection, 46.00 mg of iridium dimer (Formula (III)) was added into a 100 mL Schlenk bottle. 24.34 mg of ligand (formula (II) R1=R2=R3=hydrogen), 20 mg of sodium acetate and 10 mL of anhydrous methanol were reacted at room temperature for 12 h. After the reaction was completed, the solvent was dried by rotary evaporation, and the remaining solid was dissolved with dichloromethane. The sodium acetate was removed by sand core filtration. The filtrate was spun down to a minimum amount by rotary evaporation, and an excess of a poor solvent n-hexane was added to produce a precipitate. The precipitate was filtered by sand core and washed with n-hexane, and dried in vacuo to obtain a red solid 9.
[0032] When the complex is 10, it is prepared by the following method:
[0033] Under nitrogen protection, 45.97 mg of iridium dimer (Formula (III)) was added into a 100 mL Schlenk bottle. 26.12 mg of ligand (formula (II) R1 = fluorine, R2 = R3 = hydrogen), 20 mg of sodium acetate and 10 mL of anhydrous methanol were reacted at room temperature for 12 h. After the reaction was completed, the solvent was dried by rotary evaporation, and the remaining solid was dissolved with dichloromethane. The sodium acetate was removed by sand core filtration. The filtrate was spun down to a minimum amount by rotary evaporation, and an excess of a poor solvent n-hexane was added to produce a precipitate. The precipitate was filtered through a sand core and washed with n-hexane, and dried in vacuo to obtain a red solid 10.
[0034] When the complex is 11, it is prepared by the following method:
[0035] Under nitrogen protection, 30.24 mg of iridium dimer (Formula (III)) was added into a 100 mL Schlenk bottle. 15.62 mg of ligand (formula (II) R1=R2=R3=hydrogen), 20 mg of sodium acetate and 10 mL of anhydrous methanol were reacted at room temperature for 12 h. After the reaction was completed, the solvent was dried by rotary evaporation, and the remaining solid was dissolved with dichloromethane. The sodium acetate was removed by sand core filtration. The filtrate was spun down to a minimum amount by rotary evaporation, and an excess of a poor solvent n-hexane was added to produce a precipitate. The precipitate was filtered through a sand core and washed with n-hexane, and dried in vacuo to obtain a red solid 11.
[0036] When the complex is 12, it is prepared by the following method:
[0037] Under nitrogen protection, 35.03 mg of iridium dimer (Formula (III)) was added into a 100 mL Schlenk bottle. 19.86 mg of ligand (formula (II) R1 = fluorine, R2 = R3 = hydrogen), 20 mg of sodium acetate and 10 mL of anhydrous methanol were reacted at room temperature for 12 h. After the reaction was completed, the solvent was dried using a rotary evaporator, and the remaining solid was dissolved with dichloromethane and filtered through a sand core to remove the sodium acetate. The filtrate was spun down to a minimum using a rotary evaporator, and an excess of a poor solvent, n-hexane, was added to produce a precipitate. The precipitate was filtered through a sand core and washed with n-hexane, and dried in vacuo to obtain a red solid 12.
[0038] Beneficial Effects
[0039] (1) The present invention provides a method for preparing a carboxyl-containing half-sandwich type iridium complex, thereby obtaining a series of novel half-sandwich type complexes with good anti-tumor effects.
[0040] (2) The synthesis of the complex is as follows: the ligand and the dimer react with a base or a basic solvent B under reaction conditions to obtain a novel half-sandwich type iridium complex I.
[0041] (3) This type of carboxyl-containing half-sandwich iridium complex exhibits excellent anti-tumor effects, among which the anti-cancer activity of the carboxyl-containing complex is better than that of the non-carboxyl-containing complex, and is a very promising anti-cancer drug. BRIEF DESCRIPTION OF THE DRAWINGS
[0042] Figure 1 is the H NMR spectrum of complex 1 of the present invention.
[0043] Figure 2 is the mass spectrum of complex 1 of the present invention.
[0044] Figure 3 It is the H NMR spectrum of complex 2 of the present invention.
[0045] Figure 4 is the mass spectrum of complex 2 of the present invention.
[0046] Figure 5 The H NMR spectrum of the complex 3 of the present invention is
[0047] Figure 6 is the mass spectrum of complex 3 of the present invention.
[0048] Figure 7 It is the H NMR spectrum of complex 4 of the present invention.
[0049] Figure 8 is the mass spectrum of complex 4 of the present invention.
[0050] Fig. 9 is the H NMR spectrum of complex 5 of the present invention.
[0051] Fig.10 is the mass spectrum of complex 5 of the present invention.
[0052] Fig.11 This is the H NMR spectrum of complex 6 of the present invention.
[0053] Fig.12 is the mass spectrum of complex 6 of the present invention.
[0054] Fig.13 This is the H NMR spectrum of complex 7 of the present invention.
[0055] Fig.14 is the mass spectrum of complex 7 of the present invention.
[0056] Fig.15 is the H NMR spectrum of complex 8 of the present invention.
[0057] Fig.16 is the mass spectrum of complex 8 of the present invention.
[0058] Fig.17 is the H NMR spectrum of complex 9 of the present invention.
[0059] Fig.18 is the mass spectrum of complex 9 of the present invention.
[0060] Fig.19 is the H NMR spectrum of complex 10 of the present invention.
[0061] Fig. 20 is the mass spectrum of complex 10 of the present invention.
[0062] Fig.21 is the H NMR spectrum of complex 11 of the present invention.
[0063] Fig. 22 is the mass spectrum of complex 11 of the present invention.
[0064] Fig.23 This is the single crystal structure of complex 11 of the present invention.
[0065] Fig.24 This is the H NMR spectrum of complex 12 of the present invention.
[0066] Fig.25 This is the mass spectrum of complex 12 of the present invention.
[0067] Fig.26 This is the H NMR spectrum of the comparative example complex 13 of the present invention.
[0068] Fig. 27 It is the mass spectrum of the comparative example complex 13 of the present invention.
[0069] Fig.28 This is the H NMR spectrum of the comparative example complex 14 of the present invention.
[0070] Fig.29 It is the mass spectrum of the comparative example complex 14 of the present invention. DETAILED DESCRIPTION
[0071] The present invention is further illustrated by the following examples of some representative compounds, but these illustrations are not intended to limit the present invention.
[0072] The starting compounds used in the synthesis of the compounds are commercial products or can be prepared from known synthetic methods, and the preparation methods of all organic compounds can be obtained from the literature, and these methods are basic and obvious to synthetic chemists. Therefore, the description of the following synthetic methods can be considered to be detailed and specific.
[0073] Example 1
[0074] When the complex is 1, it is prepared by the following method:
[0075] Under nitrogen protection, 30.05 mg of iridium dimer (Formula (III)) was added into a 100 mL Schlenk bottle. 18.66 mg of ligand (formula (II) R1=R2=R3=hydrogen), 20 mg of sodium acetate and 10 mL of anhydrous methanol were reacted at room temperature for 12 h. After the reaction was completed, the solvent was dried using a rotary evaporator, and the remaining solid was dissolved with dichloromethane. The sodium acetate was removed by filtering with a sand core; the filtrate was spun down to a minimum using a rotary evaporator, and an excess of a poor solvent, n-hexane, was added to produce a precipitate. The precipitate was filtered with a sand core and washed with n-hexane, and dried in vacuo to obtain a red solid 1.
[0076] NMR characterization 1H NMR (500MHz, CD3OD) δ8.29(s,1H,CH=N),8.10–8.05(m,2H),7.88–7.81(m,2H),7.39(m,J=8.7,6.9,1. 9Hz,1H),7.32(m,J=7.9,1.9Hz,1H),6.89(d,J=8.5Hz,1H),6.57–6.52(m,1H),1.30(s,15H,Cp*-CH3).
[0077] Mass Spectrum: C 24 H 25 Theoretical value of IrNO3 is 568.14637, and the actual value is 568.1474, [M-Cl] + .
[0078] Element analysis: theoretical value C 24 H 25 ClIrNO3: C, 47.79; H, 4.18; N, 2.32, actual measured: C, 47.97; H, 4.16; N, 2.31.
[0079] Example 2
[0080] When the complex is 2, it is prepared by the following method:
[0081] Under nitrogen protection, 30.02 mg of iridium dimer (Formula (III)) was added into a 100 mL Schlenk bottle. 19.95 mg of ligand (formula (II) R1 = fluorine, R2 = R3 = hydrogen), 20 mg of sodium acetate and 10 mL of anhydrous methanol were reacted at room temperature for 12 h. After the reaction was completed, the solvent was dried using a rotary evaporator, and the remaining solid was dissolved with dichloromethane. The sodium acetate was removed by sand core filtration; the filtrate was spun down to a minimum using a rotary evaporator, and an excess of a poor solvent, n-hexane, was added to produce a precipitate. The precipitate was filtered through a sand core and washed with n-hexane, and dried in vacuo to obtain a red solid 2.
[0082] NMR characterization 1 H NMR (500MHz, CD3OD) δ8.37(s,1H,CH=N),7.94(t,J=8.1Hz,1H),7.78(d,J=11.9Hz,1H),7.56(m,J=8.4,2.2Hz,1H), 7.44–7.40(m,1H),7.35(m,J=8.1,1.9Hz,1H),6.93(d,J=8.5Hz,1H),6.58(t,J=7.4Hz,1H),1.34(s,15H,Cp*-CH3).
[0083] Mass Spectrum: C 24 H24 Theoretical value of FIrNO3 is 586.13695, and the actual value is 586.1371, [M-Cl] + .
[0084] Element analysis: Theoretical value C 24 H 24 FClIrNO3: C, 46.41; H, 3.89; N, 2.26, actual measured: C, 46.59; H, 3.87; N, 2.25.
[0085] Example 3
[0086] When the complex is 3, it is prepared by the following method:
[0087] Under nitrogen protection, 30.02 mg of iridium dimer (Formula (III)) was added into a 100 mL Schlenk bottle. 22.89 mg of ligand (formula (II) R1 = R2 = hydrogen, R3 = tert-butyl), 20 mg of sodium acetate and 10 mL of anhydrous methanol were reacted at room temperature for 12 h. After the reaction was completed, the solvent was dried using a rotary evaporator, and the remaining solid was dissolved with dichloromethane. The sodium acetate was removed by sand core filtration; the filtrate was spun down to a minimum using a rotary evaporator, and an excess of a poor solvent, n-hexane, was added to produce a precipitate. The precipitate was filtered through a sand core and washed with n-hexane, and dried in vacuo to obtain a red solid 3.
[0088] NMR characterization 1 H NMR (500MHz, CD3OD) δ8.16–8.03(m,3H),7.56(d,J=8.1Hz,2H),7.40–7.34(m,1H),7.04(d,J=7.3 Hz,1H),6.42(t,J=7.8Hz,1H),1.46(t,J=3.1Hz,9H,C(CH3)3),1.38(d,J=2.4Hz,15H,Cp*-CH3).
[0089] Mass Spectrum: C 28 H 33 Theoretical value of IrNO3 is 624.20897, and the actual value is 624.20678, [M-Cl] + .
[0090] Element analysis: Theoretical value C 28 H 33 ClIrNO3: C, 51.01; H, 5.05; N, 2.12, actual measured: C, 51.22; H, 5.03; N, 2.11.
[0091] Example 4
[0092] When the complex is 4, it is prepared by the following method:
[0093] Under nitrogen protection, 30.02 mg of iridium dimer (Formula (III)) was added into a 100 mL Schlenk bottle. 23.96 mg of ligand (formula (II) R1 = fluorine, R2 = hydrogen, R3 = tert-butyl), 20 mg of sodium acetate and 10 mL of anhydrous methanol were reacted at room temperature for 12 h. After the reaction was completed, the solvent was dried using a rotary evaporator, and the remaining solid was dissolved with dichloromethane. The sodium acetate was removed by sand core filtration; the filtrate was spun down to a minimum using a rotary evaporator, and an excess of a poor solvent, n-hexane, was added to produce a precipitate. The precipitate was filtered through a sand core and washed with n-hexane, and dried in vacuo to obtain a red solid 4.
[0094] NMR characterization 1 H NMR(500MHz,CD3OD)δ8.31(s,1H,CH=N),7.91(t,J=8.0Hz,1H),7.49–7.44(m,2H),7.33(m,J=8.3,2.1Hz,1H), 7.14(m,J=7.9,1.8Hz,1H),6.54(t,J=7.5Hz,1H),1.49(s,9H,C(CH3)3),1.44(d,J=1.1Hz,15H,Cp*-CH3). Mass spectrum: C 28 H 32 Theoretical value of FIrNO3 is 642.19955, and the actual value is 642.2005, [M-Cl] + .
[0095] Element analysis: Theoretical value C 28 H 32 FClIrNO3: C, 49.66; H, 4.76; N, 2.07, actual measured: C, 49.82; H, 4.74; N, 2.06.
[0096] Example 5
[0097] When the complex is 5, it is prepared by the following method:
[0098] Under nitrogen protection, 30.05 mg of iridium dimer (Formula (III)) was added into a 100 mL Schlenk bottle. 26.78 mg of ligand (formula (II) R1 = hydrogen, R2 = R3 = tert-butyl), 20 mg of sodium acetate and 10 mL of anhydrous methanol were reacted at room temperature for 12 h. After the reaction was completed, the solvent was dried using a rotary evaporator, and the remaining solid was dissolved with dichloromethane. The sodium acetate was removed by sand core filtration; the filtrate was spun down to a minimum using a rotary evaporator, and an excess of a poor solvent, n-hexane, was added to produce a precipitate. The precipitate was filtered through a sand core and washed with n-hexane, and dried in vacuo to obtain a red solid 5.
[0099] NMR characterization 1 H NMR (500MHz, CD3OD) δ8.17(s,1H,CH=N),8.11(d,J=8.4Hz,2H),7.59(d,J=8.4Hz,2H),7.54(d,J=2.6 Hz,1H),7.03(d,J=2.6Hz,1H),1.49(s,9H,C(CH3)3),1.39(s,15H,Cp*-CH3),1.25(s,9H,C(CH3)3).
[0100] Mass Spectrum: C 32 H 41 Theoretical value of IrNO3 is 680.27157, and the actual value is 680.26913, [M-Cl] + .
[0101] Element analysis: Theoretical value C 32 H 41 ClIrNO3: C, 53.73; H, 5.78; N, 1.96, actual measured: C, 53.95; H, 5.76; N, 1.95.
[0102] Example 6
[0103] When the complex is 6, it is prepared by the following method:
[0104] Under nitrogen protection, 29.99 mg of iridium dimer (Formula (III)) was added into a 100 mL Schlenk bottle. 28.12 mg of ligand (formula (II) R1 = fluorine, R2 = R3 = tert-butyl), 20 mg of sodium acetate and 10 mL of anhydrous methanol were reacted at room temperature for 12 h. After the reaction was completed, the solvent was dried using a rotary evaporator, and the remaining solid was dissolved with dichloromethane. The sodium acetate was removed by filtering with a sand core. The filtrate was spun down to a minimum using a rotary evaporator, and an excess of a poor solvent, n-hexane, was added to produce a precipitate. The precipitate was filtered with a sand core and washed with n-hexane, and dried in vacuo to obtain a red solid 6.
[0105] NMR characterization 1H NMR (500MHz, CD3OD) δ8.51(s,1H,CH=N),7.86(t,J=8.0Hz,1H),7.68(d,J=2.5Hz,1H),7.41(d,J=10.2Hz,1H),7.28 (m,J=8.2,2.1Hz,1H),7.21(d,J=2.6Hz,1H),1.54(s,9H,C(CH3)3),1.48(s,15H,Cp*-CH3),1.27(s,9H,C(CH3)3).
[0106] Mass Spectrum: C 32 H 40 Theoretical value of FIrNO3 is 698.26215, and the actual value is 698.2632, [M-Cl] + .
[0107] Element analysis: Theoretical value C 32 H 40 FClIrNO3: C, 52.41; H, 5.50; N, 1.91, actual measured: C, 52.62; H, 5.48; N, 1.90.
[0108] Example 7
[0109] When the complex is 7, it is prepared by the following method:
[0110] Under nitrogen protection, 54.98 mg of iridium dimer (Formula (III)) was added into a 100 mL Schlenk bottle. 24.88 mg of ligand (formula (II) R1=R2=R3=hydrogen), 20 mg of sodium acetate and 10 mL of anhydrous methanol were reacted at room temperature for 12 h. After the reaction was completed, the solvent was dried using a rotary evaporator, and the remaining solid was dissolved with dichloromethane. The sodium acetate was removed by sand core filtration; the filtrate was spun down to a minimum using a rotary evaporator, and an excess of a poor solvent, n-hexane, was added to produce a precipitate. The precipitate was filtered through a sand core and washed with n-hexane, and dried in vacuo to obtain a red solid 7.
[0111] NMR characterization 1 H NMR (500MHz, CD3OD) δ8.32(s,1H,CH=N),7.99(d,J=8.4Hz,2H),7.73(d,J=8.5Hz,2H),7.62–7.59(m,2H ),7.52(d,J=8.2Hz,2H),7.43–7.35(m,7H),6.92(d,J=8.5Hz,1H),6.59(t,J=7.4Hz,1H),1.54(s,6H,Cp biph -CH3),1.16(s,6H,Cp biph-CH3).
[0112] Mass Spectrum: C 35 H 31 Theoretical value of IrNO3 is 706.19332, and the actual value is 706.1935, [M-Cl] + .
[0113] Element analysis: Theoretical value C 35 H 31 ClIrNO3: C, 56.71; H, 4.22; N, 1.89, actual measured: C, 56.90; H, 4.20; N, 1.88.
[0114] Example 8
[0115] When the complex is 8, it is prepared by the following method:
[0116] Under nitrogen protection, 50.06 mg of iridium dimer (Formula (III)) was added into a 100 mL Schlenk bottle. 24.55 mg of ligand (formula (II) R1 = fluorine, R2 = R3 = hydrogen), 20 mg of sodium acetate and 10 mL of anhydrous methanol were reacted at room temperature for 12 h. After the reaction was completed, the solvent was dried using a rotary evaporator, and the remaining solid was dissolved with dichloromethane. The sodium acetate was removed by filtering with a sand core. The filtrate was spun down to a minimum using a rotary evaporator, and an excess of a poor solvent, n-hexane, was added to produce a precipitate. The precipitate was filtered with a sand core and washed with n-hexane, and dried in vacuo to obtain a red solid 8.
[0117] NMR characterization 1 H NMR (500MHz, CD3OD) δ8.31(s,1H,CH=N),7.81(s,1H),7.60(d,J=7.2Hz,2H),7.52(d,J=8 .3Hz,2H),7.44–7.33(m,9H),6.91(d,J=8.6Hz,1H),6.58(t,J=7.4Hz,1H),1.56(s,6H,Cp biph -CH3),1.21(s,6H,Cp biph -CH3). Mass Spectrum: C 35 H 30 Theoretical value of FIrNO3 is 724.18390, and the actual value is 724.1841, [M-Cl] + .
[0118] Element analysis: Theoretical value C 35 H 30 ClFIrNO3: C, 55.37; H, 3.98; N, 1.84, actual measured: C, 55.50; H, 3.96; N, 1.83.
[0119] Example 9
[0120] When the complex is 9, it is prepared by the following method:
[0121] Under nitrogen protection, 46.00 mg of iridium dimer (Formula (III)) was added into a 100 mL Schlenk bottle. 24.34 mg of ligand (formula (II) R1=R2=R3=hydrogen), 20 mg of sodium acetate and 10 mL of anhydrous methanol were reacted at room temperature for 12 h. After the reaction was completed, the solvent was dried using a rotary evaporator, and the remaining solid was dissolved with dichloromethane. The sodium acetate was removed by filtering with a sand core. The filtrate was spun down to a minimum using a rotary evaporator, and an excess of a poor solvent, n-hexane, was added to produce a precipitate. The precipitate was filtered through a sand core and washed with n-hexane, and dried in vacuo to obtain a red solid 9.
[0122] NMR characterization 1 H NMR (500MHz, CD3OD) δ8.30(s,1H,CH=N),7.97(d,J=8.6Hz,2H),7.68(d,J=8.5Hz,2H),7. 42(s,1H),7.32–7.26(m,6H),6.90(d,J=8.5Hz,1H),6.58(t,J=6.9Hz,1H),1.54(s,6H,Cp biph -CH3),1.09(s,6H,Cp biph -CH3). Mass Spectrum: C 29 H 27 Theoretical value of IrNO3 is 630.16202, and the actual value is 630.1633, [M-Cl] + .
[0123] Element analysis: Theoretical value C 29 H 27 ClIrNO3: C, 52.36; H, 4.09; N, 2.11, actual measured: C, 52.55; H, 4.07; N, 2.10.
[0124] Example 10
[0125] When the complex is 10, it is prepared by the following method:
[0126] Under nitrogen protection, 45.97 mg of iridium dimer (Formula (III)) was added into a 100 mL Schlenk bottle. 26.12 mg of ligand (formula (II) R1 = fluorine, R2 = R3 = hydrogen), 20 mg of sodium acetate and 10 mL of anhydrous methanol were reacted at room temperature for 12 h. After the reaction was completed, the solvent was dried using a rotary evaporator, and the remaining solid was dissolved with dichloromethane. The sodium acetate was removed by sand core filtration; the filtrate was spun down to a minimum using a rotary evaporator, and an excess of a poor solvent, n-hexane, was added to produce a precipitate. The precipitate was filtered through a sand core and washed with n-hexane, and dried in vacuo to obtain a red solid 10.
[0127] NMR characterization 1 H NMR (500MHz, CD3OD) δ8.30(s,1H,CH=N),7.82(t,J=8.1Hz,1H),7.64(d,J=14.0Hz,1H),7.44 –7.36(m,3H),7.33–7.26(m,5H),6.88(d,J=8.5Hz,1H),6.58(t,J=7.4Hz,1H),1.55(s,6H,Cp biph -CH3),1.15(s,6H,Cp biph -CH3).
[0128] Mass Spectrum: C 29 H 26 Theoretical value of FIrNO3 is 648.15260, and the actual value is 648.1534, [M-Cl] + .
[0129] Element analysis: Theoretical value C 29 H 26 ClFIrNO3: C, 55.31; H, 4.32; N, 2.22, actual measured: C, 55.52; H, 4.30; N, 2.21.
[0130] Embodiment 11
[0131] When the complex is 11, it is prepared by the following method:
[0132] Under nitrogen protection, 30.24 mg of iridium dimer (Formula (III)) was added into a 100 mL Schlenk bottle. 15.62 mg of ligand (formula (II) R1 = R2 = R3 = hydrogen), 20 mg of sodium acetate and 10 mL of anhydrous methanol were reacted at room temperature for 12 hours. After the reaction, the solvent was dried by rotary evaporation, and the remaining solid was dissolved with dichloromethane. The sodium acetate was removed by sand core filtration. The filtrate was spun down to a minimum amount by rotary evaporation, and an excess of poor solvent n-hexane was added to produce a precipitate. The precipitate was filtered through a sand core and washed with n-hexane, and dried in vacuo to obtain a red solid 11. Single crystals can be obtained by slowly diffusing n-hexane into a dichloromethane solution of the complex 11 at room temperature. NMR characterization is 1H NMR (500MHz, CD3OD) δ8.37(s,1H,CH=N),8.00(d,J=8.3Hz,2H),7.69(d,J=8.2Hz,2H),7.40(d,J=7.8Hz,2H),7.23–7. 19(m,3H),6.96(d,J=7.4Hz,1H),6.87(d,J=8.5Hz,1H),6.59(t,J=7.4Hz,1H),2.05(s,3H,arene-CH3),1.60(s,6H,Cp biph -CH3), 0.90(s,6H,Cp biph -CH3).
[0133] Mass Spectrum: C 30 H 29 Theoretical value of IrNO3 is 644.17767, and the actual value is 644.1776, [M-Cl] + .
[0134] Element analysis: Theoretical value C 30 H 29 ClIrNO3: C, 53.05; H, 4.30; N, 2.06, actual measured: C, 53.27; H, 4.28; N, 2.05.
[0135] Example 12
[0136] When the complex is 12, it is prepared by the following method:
[0137] Under nitrogen protection, 35.03 mg of iridium dimer (Formula (III)) was added into a 100 mL Schlenk bottle. 19.86 mg of ligand (formula (II) R1 = fluorine, R2 = R3 = hydrogen), 20 mg of sodium acetate and 10 mL of anhydrous methanol were reacted at room temperature for 12 h. After the reaction was completed, the solvent was dried using a rotary evaporator, and the remaining solid was dissolved with dichloromethane and filtered through a sand core to remove the sodium acetate. The filtrate was spun down to a minimum using a rotary evaporator, and an excess of a poor solvent, n-hexane, was added to produce a precipitate. The precipitate was filtered through a sand core and washed with n-hexane, and dried in vacuo to obtain a red solid 12.
[0138] NMR characterization 1H NMR (500MHz, CD3OD) δ8.37(s,1H,CH=N),7.82(t,J=7.9Hz,1H),7.67(d,J=11.5Hz,1H),7.41(t,J=7.8Hz,3H),7.24–7. 18(m,3H),6.95(t,J=7.3Hz,1H),6.85(d,J=8.5Hz,1H),6.59(t,J=7.4Hz,1H),2.06(s,3H,arene-CH3),1.61(s,6H,Cp biph -CH3), 0.93(s,6H,Cp biph -CH3).
[0139] Mass Spectrum: C 30 H 28 Theoretical value of FIrNO3 is 662.16825, and the actual value is 662.1768, [M-Cl] + .
[0140] Element analysis: Theoretical value C 30 H 28 ClFIrNO3: C, 51.68; H, 4.05; N, 2.01, actual measured: C, 51.85; H, 4.03; N, 2.00.
[0141] Comparative Example 1
[0142] When the complex is 13, it is prepared by the following method:
[0143] Under nitrogen protection, 49.98 mg of iridium dimer (Formula (III)) was added to a 100 mL Schlenk bottle. 20.06 mg of ligand (formula (II) R1=R2=R3=hydrogen, no COOH), 20 mg of sodium acetate and 10 mL of anhydrous methanol were reacted at room temperature for 12 h. After the reaction was completed, the solvent was dried using a rotary evaporator, and the remaining solid was dissolved with dichloromethane and filtered through a sand core to remove the sodium acetate. The filtrate was spun down to a minimum using a rotary evaporator, and an excess of a poor solvent, n-hexane, was added to produce a precipitate. The precipitate was filtered through a sand core and washed with n-hexane, and dried in vacuo to obtain a red solid 13.
[0144] NMR characterization 1H NMR (500MHz, CD3OD) δ8.11(s,1H,CH=N),7.48(d,J=8.7Hz,2H),7.42(d,J=6.7Hz,2H),7.40–7.37(m,2H),7.31(t,J=7.6Hz,2H),7.27(s,2H) ,7.26(s,1H),7.22(d,J=10.0Hz,2H),7.04(d,J=8.3Hz,2H),6.79(d,J=8.5Hz,1H),6.48–6.44(m,1H),2.24(s,3H,Aryl-CH3),1.43(s,6H,Cp biph -CH3),1.01(s,6H,Cp biph -CH3).
[0145] Mass Spectrum: C 35 H 33 Theoretical value of IrNO is 676.2191, and the actual value is 676.2220, [M-Cl] + .
[0146] Element analysis: Theoretical value C 35 H 33 ClIrNO: C, 59.10; H, 4.68; N, 1.97, actual measured: C, 59.29; H, 4.66; N, 1.96.
[0147] Comparative Example 2
[0148] When the complex is 14, it is prepared by the following method:
[0149] Under nitrogen protection, 50.05 mg of iridium dimer (Formula (III)) was added into a 100 mL Schlenk bottle. 21.98 mg of ligand (formula (II) R1 = fluorine, R2 = R3 = hydrogen, no COOH), 20 mg of sodium acetate and 10 mL of anhydrous methanol were reacted at room temperature for 12 h. After the reaction was completed, the solvent was dried using a rotary evaporator, and the remaining solid was dissolved with dichloromethane. The sodium acetate was removed by sand core filtration; the filtrate was spun down to a minimum using a rotary evaporator, and an excess of a poor solvent, n-hexane, was added to produce a precipitate. The precipitate was filtered through a sand core and washed with n-hexane, and dried in vacuo to obtain a red solid 14.
[0150] The NMR characterization is: 1H NMR (500MHz, CD3OD) δ8.14(s,1H,CH=N),7.50–7.43(m,3H),7.39(d,J=8.2Hz,2H),7.32(t,J=7.7Hz,3H),7.27(d,J=8.2Hz,2H),7.23(d,J =4.1Hz,2H),7.16(d,J=8.2Hz,1H),7.08(t,J=8.2Hz,1H),6.79(d,J=8.6Hz,1H),6.49–6.45(m,1H),2.16(s,3H,Aryl-CH3),1.43(s,6H,Cp biph -CH3),1.07(s,6H,Cp biph -CH3).
[0151] Mass Spectrum: C 35 H 32 Theoretical value of FIrNO is 694.2097, and the actual value is 694.2098, [M-Cl] + .
[0152] Element analysis: Theoretical value C 35 H 32 ClFIrNO: C, 60.59; H, 4.65; N, 2.02, actual measured: C, 60.78; H, 4.63; N, 2.01
[0153] Example 13
[0154] Experimental study on the proliferation inhibition of tumor cell lines by complexes 1-12 with anticancer activity:
[0155] (1) Preparation of test compounds: Dissolve the solid complex in DMSO to prepare a stock solution of a certain concentration, further dilute the stock solution with cell culture medium until the working concentration is reached, and culture for 24 h;
[0156] (2) Cell growth inhibition assay (MTT method):
[0157] 1) Take 5000 human cervical cancer cells (HeLa) and human non-small cell lung cancer cells (A549), prepare cell suspensions, and inoculate them in 96-well culture plates;
[0158] 2) Pre-culture cells with drug-free medium, incubate at 5% CO2, 310K for 24 hours, add the prepared test compound, and culture for 24 hours;
[0159] 3) Add 15 μL of 5 mg / mL MTT solution to each well and continue culturing for 4 hours to form a purple crystalline substance, formazan;
[0160] 4) Terminate the culture, carefully remove the culture medium in the wells, add 100 μL of DMSO to each well to fully dissolve the formazan precipitate, mix on an oscillator, and measure the optical density of each well with a microplate reader at a wavelength of 570 nm;
[0161] 5) Each experiment was repeated three times, IC 50 = Mean ± SEM. The inhibition rates of complexes 1-12 and commercial cisplatin on the growth of cancer cells HeLa and A549 are shown in Table 1.
[0162] Table 1
[0163]
[0164] It can be seen from Table 1 that the complexes all show good anticancer activity, and some complexes are close to the activity of commercialized cisplatin. And by comparing the carboxyl-containing complex 7 and the carboxyl-free complex 13, as well as the carboxyl-containing complex 8 and the carboxyl-free complex 14, it is found that the anticancer activity of the carboxyl-containing complex is better than that of the carboxyl-free complex. By comparing complexes 1-12, it can be seen that the change of the substituents R1-R3 on the ligand has little effect on the anticancer activity of the complex; by comparing complexes 1, 7, 9 or complexes 2, 8, 10, it is found that the introduction of an aromatic group on the cyclopentadienyl R4 will enhance its anticancer activity, among which the complex substituted with biphenyl on the cyclopentadienyl has the best activity. The above conclusions provide a theoretical basis for the preparation of new anti-tumor drugs.
[0165] Obviously, those skilled in the art can make various changes and modifications to the present invention without departing from the spirit and scope of the present invention. Thus, if these modifications and variations of the present invention fall within the scope of the claims of the present invention and their equivalents, the present invention is also intended to include these modifications and variations.
Claims
1. A carboxyl-containing half-sandwich type iridium complex, characterized in that: The structural formula is shown in formula (I): In the formula, R1, R2, and R3 are simultaneously or separately hydrogen, C1-C 15 Alkyl, halogen or halogenated C1~C 15 An alkyl group; R4 is R5 is one of Cl, CH3O, CH3COO, and triphenylphosphine.
2. The carboxyl-containing half-sandwich type iridium complex according to claim 1, characterized in that In the formula (I), R1 is hydrogen, R2 is hydrogen, R3 is hydrogen, and R4 is R5 is Cl, and the specific structural formula is shown in Formula 1; in Formula (I), R1 is fluorine, R2 is hydrogen, R3 is hydrogen, and R4 is R5 is Cl, and the specific structural formula is shown in Formula 2; in the formula (I), R1 is hydrogen, R2 is hydrogen, R3 is tert-butyl, and R4 is R5 is Cl, and the specific structural formula is shown in Formula 3; in Formula (I), R1 is fluorine, R2 is hydrogen, R3 is tert-butyl, and R4 is R5 is Cl, and the specific structural formula is shown in Formula 4; in Formula (I), R1 is hydrogen, R2 is tert-butyl, R3 is tert-butyl, and R4 is R5 is Cl, and the specific structural formula is shown in Formula 5; in the formula (I), R1 is fluorine, R2 is tert-butyl, R3 is tert-butyl, and R4 is R5 is Cl, and the specific structural formula is shown in Formula 6; in Formula (I), R1 is hydrogen, R2 is hydrogen, R3 is hydrogen, and R4 is R5 is Cl, and the specific structural formula is shown in Formula 7; in Formula (I), R1 is fluorine, R2 is hydrogen, R3 is hydrogen, and R4 is R5 is Cl, and the specific structural formula is shown in Formula 8; in the formula (I), R1 is hydrogen, R2 is hydrogen, R3 is hydrogen, and R4 is R5 is Cl, and the specific structural formula is shown in Formula 9; in Formula (I), R1 is fluorine, R2 is hydrogen, R3 is hydrogen, and R4 is R5 is Cl, and the specific structural formula is shown in Formula 10; in Formula (I), R1 is hydrogen, R2 is hydrogen, R3 is hydrogen, and R4 is R5 is Cl, and the specific structural formula is shown in Formula 11; in Formula (I), R1 is fluorine, R2 is hydrogen, R3 is hydrogen, and R4 is R5 is Cl, and the specific structural formula is shown in Formula 12; 3. A method for preparing a carboxyl-containing half-sandwich type iridium complex according to claim 1 or 2, characterized in that: The following steps are involved: Under nitrogen protection, the dimer represented by formula (III), the carboxyl-containing ligand represented by formula (II), and a base or alkaline solvent B are reacted at room temperature for 24 hours with methanol as solvent to obtain a carboxyl-containing half-sandwich type iridium complex represented by formula (I); the complex is an 18-electron complex. When sodium methoxide or sodium acetate is added as B, the purpose is to remove a proton H on the phenolic hydroxyl group of the ligand to make the ligand become anionic ligand and coordinate with the metal center as a N^O chelating ligand; the specific synthesis route is:
4. The preparation method according to claim 3, characterized in that: When the complex is 1, it is prepared by the following method: Under nitrogen protection, 30.05 mg of iridium dimer (formula (III) R4= ), 18.66 mg of ligand (formula (II) R1 = R2 = R3 = hydrogen), 20 mg of sodium acetate and 10 mL of anhydrous methanol, react at room temperature for 12 h. After the reaction is completed, the solvent is dried by rotary evaporation, the remaining solid is dissolved with dichloromethane, and the sodium acetate is removed by sand core filtration; the filtrate is spun down to a minimum amount by rotary evaporation, and an excess of poor solvent n-hexane is added to produce a precipitate, the precipitate is filtered by sand core and washed with n-hexane, and dried in vacuo to obtain a red solid 1; When the complex is 2, it is prepared by the following method: Under nitrogen protection, 30.02 mg of iridium dimer (formula (III) R4= ), 19.95 mg of ligand (formula (II) R1 = fluorine, R2 = R3 = hydrogen), 20 mg of sodium acetate and 10 mL of anhydrous methanol, react at room temperature for 12 h. After the reaction is completed, the solvent is dried by rotary evaporation, the remaining solid is dissolved with dichloromethane, and the sodium acetate is removed by sand core filtration; the filtrate is spun down to a minimum amount by rotary evaporation, and excess poor solvent n-hexane is added to produce a precipitate, the precipitate is filtered by sand core and washed with n-hexane, and dried in vacuo to obtain a red solid 2; When the complex is 3, it is prepared by the following method: Under nitrogen protection, 30.02 mg of iridium dimer (formula (III) R4= ), 22.89 mg of ligand (formula (II) R1 = R2 = hydrogen, R3 = tert-butyl), 20 mg of sodium acetate and 10 mL of anhydrous methanol, react at room temperature for 12 h. After the reaction is completed, the solvent is dried by rotary evaporation, the remaining solid is dissolved with dichloromethane, and the sodium acetate is removed by sand core filtration; the filtrate is spun down to a minimum amount by rotary evaporation, and excess poor solvent n-hexane is added to produce a precipitate, the precipitate is filtered by sand core and washed with n-hexane, and dried in vacuo to obtain a red solid 3; When the complex is 4, it is prepared by the following method: Under nitrogen protection, 30.02 mg of iridium dimer (formula (III) R4= ), 23.96 mg of ligand (formula (II) R1 = fluorine, R2 = hydrogen, R3 = tert-butyl), 20 mg of sodium acetate and 10 mL of anhydrous methanol, react at room temperature for 12 h. After the reaction is completed, the solvent is dried by rotary evaporation, the remaining solid is dissolved with dichloromethane, and the sodium acetate is removed by sand core filtration; the filtrate is spun down to a minimum amount by rotary evaporation, and excess poor solvent n-hexane is added to produce a precipitate, the precipitate is filtered by sand core and washed with n-hexane, and dried in vacuo to obtain a red solid 4; When the complex is 5, it is prepared by the following method: Under nitrogen protection, 30.05 mg of iridium dimer (formula (III) R4= ), 26.78 mg of ligand (formula (II) R1 = hydrogen, R2 = R3 = tert-butyl), 20 mg of sodium acetate and 10 mL of anhydrous methanol, react at room temperature for 12 h. After the reaction is completed, the solvent is dried by rotary evaporation, the remaining solid is dissolved with dichloromethane, and the sodium acetate is removed by sand core filtration; the filtrate is spun down to a minimum amount by rotary evaporation, and excess poor solvent n-hexane is added to produce a precipitate, the precipitate is filtered by sand core and washed with n-hexane, and dried in vacuo to obtain a red solid 5; When the complex is 6, it is prepared by the following method: Under nitrogen protection, 29.99 mg of iridium dimer (formula (III) R4= ), 28.12 mg of ligand (formula (II) R1 = fluorine, R2 = R3 = tert-butyl), 20 mg of sodium acetate and 10 mL of anhydrous methanol, react at room temperature for 12 h. After the reaction is completed, the solvent is dried by rotary evaporation, the remaining solid is dissolved with dichloromethane, and the sodium acetate is removed by sand core filtration; the filtrate is spun down to a minimum amount by rotary evaporation, and excess poor solvent n-hexane is added to produce a precipitate, the precipitate is filtered by sand core and washed with n-hexane, and dried in vacuo to obtain a red solid 6; When the complex is 7, it is prepared by the following method: Under nitrogen protection, 54.98 mg of iridium dimer (formula (III) R4= ), 24.88 mg of ligand (formula (II) R1 = R2 = R3 = hydrogen), 20 mg of sodium acetate and 10 mL of anhydrous methanol, react at room temperature for 12 h. After the reaction is completed, the solvent is dried by rotary evaporation, the remaining solid is dissolved with dichloromethane, and the sodium acetate is removed by sand core filtration; the filtrate is spun down to a minimum amount by rotary evaporation, and excess poor solvent n-hexane is added to produce a precipitate, the precipitate is filtered by sand core and washed with n-hexane, and dried in vacuo to obtain a red solid 7; When the complex is 8, it is prepared by the following method: Under nitrogen protection, 50.06 mg of iridium dimer (formula (III) R4= ), 24.55 mg of ligand (formula (II) R1 = fluorine, R2 = R3 = hydrogen), 20 mg of sodium acetate and 10 mL of anhydrous methanol, react at room temperature for 12 h. After the reaction is completed, the solvent is dried by rotary evaporation, the remaining solid is dissolved with dichloromethane, and the sodium acetate is removed by sand core filtration; the filtrate is spun down to a minimum amount by rotary evaporation, and excess poor solvent n-hexane is added to produce a precipitate, the precipitate is filtered by sand core and washed with n-hexane, and dried in vacuo to obtain a red solid 8; When the complex is 9, it is prepared by the following method: Under nitrogen protection, 46.00 mg of iridium dimer (formula (III) R4= ), 24.34 mg of ligand (formula (II) R1 = R2 = R3 = hydrogen), 20 mg of sodium acetate and 10 mL of anhydrous methanol, react at room temperature for 12 h. After the reaction is completed, the solvent is dried by rotary evaporation, the remaining solid is dissolved with dichloromethane, and the sodium acetate is removed by sand core filtration; the filtrate is spun down to a minimum amount by rotary evaporation, and excess poor solvent n-hexane is added to produce a precipitate, the precipitate is filtered by sand core and washed with n-hexane, and dried in vacuo to obtain a red solid 9; When the complex is 10, it is prepared by the following method: Under nitrogen protection, 45.97 mg of iridium dimer (formula (III) R4= ), 26.12 mg of ligand (formula (II) R1 = fluorine, R2 = R3 = hydrogen), 20 mg of sodium acetate and 10 mL of anhydrous methanol, react at room temperature for 12 h. After the reaction is completed, the solvent is dried by rotary evaporation, the remaining solid is dissolved with dichloromethane, and the sodium acetate is removed by sand core filtration; the filtrate is spun down to a minimum amount by rotary evaporation, and excess poor solvent n-hexane is added to produce a precipitate, the precipitate is filtered by sand core and washed with n-hexane, and dried in vacuo to obtain a red solid 10; When the complex is 11, it is prepared by the following method: Under nitrogen protection, 30.24 mg of iridium dimer (formula (III) R4= ), 15.62 mg of ligand (formula (II) R1 = R2 = R3 = hydrogen), 20 mg of sodium acetate and 10 mL of anhydrous methanol, react at room temperature for 12 h. After the reaction is completed, the solvent is dried by rotary evaporation, the remaining solid is dissolved with dichloromethane, and the sodium acetate is removed by sand core filtration; the filtrate is spun down to a minimum amount by rotary evaporation, and excess poor solvent n-hexane is added to produce a precipitate, the precipitate is filtered by sand core and washed with n-hexane, and dried in vacuo to obtain a red solid 11; When the complex is 12, it is prepared by the following method: Under nitrogen protection, 35.03 mg of iridium dimer (formula (III) R4= ), 19.86 mg of ligand (formula (Ⅱ) R1 = fluorine, R2 = R3 = hydrogen), 20 mg of sodium acetate and 10 mL of anhydrous methanol, react at room temperature for 12 hours. After the reaction is completed, the solvent is dried on a rotary evaporator, and the remaining solid is dissolved with dichloromethane and filtered through a sand core to remove the sodium acetate; the filtrate is spun down to a minimum using a rotary evaporator, and an excess of a poor solvent, n-hexane, is added to produce a precipitate, which is filtered through a sand core and washed with n-hexane, and dried in vacuo to obtain a red solid 12.
5. Use of the carboxyl-containing half-sandwich type iridium complex according to any one of claims 1 to 2 in the preparation of anticancer drugs.
6. The use according to claim 5, characterized in that: The cancer is liver cancer, lung cancer or cervical cancer.
Citation Information
Patent Citations
Semi-sandwich type complex containing [N,N] anion ligand, intermediate as well as preparation methods of complex and intermediate and application
CN113480577A
